Elevation Wealth Partners’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.73K Buy
9
+7
+350% +$1.14K ﹤0.01% 1253
2026
Q2
$273 Hold
2
– – ﹤0.01% 1286
2026
Q1
$236 Hold
2
– – ﹤0.01% 1060
2025
Q4
$328 Hold
2
– – ﹤0.01% 926
2025
Q3
$268 Buy
+2
New +$243 ﹤0.01% 846

Other funds holding RGEN

Elevation Wealth Partners's RGEN Position: Q3 2026 in Review

Elevation Wealth Partners increased its Repligen (RGEN) stake by 350% in Q3 2026, buying an estimated $1.14K and bringing the position to 9 shares worth $1.73K. The position accounts for ﹤0.01% of the portfolio, ranked #1253.

Elevation Wealth Partners first reported a position in RGEN in Q3 2025 and has held it in 5 quarters since. 16 funds tracked by Wall St. Rank hold RGEN as of Q3 2026.

  • Elevation Wealth Partners held 9 shares of Repligen worth $1.73K as of Q3 2026.
  • Elevation Wealth Partners bought 7 Repligen shares in Q3 2026, an estimated $1.14K.
  • Repligen made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q3 2026, its #1253 holding.
  • Elevation Wealth Partners first reported a position in Repligen in Q3 2025 and has held it in 5 quarters since.
  • 16 funds tracked by Wall St. Rank held Repligen as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.